Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain
- 1 July 2001
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 158 (7) , 1058-1066
- https://doi.org/10.1176/appi.ajp.158.7.1058
Abstract
Measures of cholinergic transmitter activity were investigated in patients with autism because of reported neuropathological abnormalities in cholinergic nuclei in the basal forebrain. Levels of cholinergic enzyme and receptor activity were measured in the frontal and parietal cerebral cortex of deceased autistic adults, similarly aged normal adults without mental retardation, and nonautistic mentally retarded adults. The immunoreactivity levels of brain-derived neurotrophic factor and nerve growth factor were measured in the basal forebrain. There were no differences between the autistic and comparison groups in choline acetyltransferase or acetylcholinesterase activity in the cerebral cortex and basal forebrain or in muscarinic M(2) receptor or alpha-bungarotoxin binding within the cortex. Cortical M(1) receptor binding was up to 30% lower than normal in the autistic subjects, and the difference reached significance in the parietal cortex. In both the parietal and frontal cortices, differences in nicotinic receptors assessed by [(3)H]epibatidine binding were significant and extensive (65%-73% lower in the autistic group than in the normal subjects); there were no differences in nicotine binding in the basal forebrain. Immunochemical analysis indicated lower levels of both the alpha(4) and beta(2) nicotinic receptor subunits in the parietal cortex. The M(1) receptor abnormality was not evident in the nonautistic group with mental retardation, although the lower [(3)H]epibatidine binding was apparent. In the basal forebrain, the level of brain-derived neurotrophic factor in the autistic group was three times as high as the level of the normal group. These neurochemical abnormalities implicate the cholinergic system in developmental disorders such as autism and suggest the potential for intervention based on cholinergic receptor modulation.Keywords
This publication has 42 references indexed in Scilit:
- Clinical neurochemistry: developments in dementia research based on brain bank materialJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Correlation of nicotinic binding with neurochemical markers in Alzheimer's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- The sympathetic skin response in peripheral autonomic failure — evaluation in pure autonomic failure, pure cholinergic dysautonomia and dopamine-beta-hydroxylase deficiencyClinical Autonomic Research, 1998
- Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophreniaBiological Psychiatry, 1995
- Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disordersJournal of Autism and Developmental Disorders, 1994
- Molecular Cloning and Chromosomal Localization of the Human α7-Nicotinic Receptor Subunit Gene (CHRNA7)Genomics, 1994
- Nucleus basalis lesions in neonate rats induce a selective cortical cholinergic hypofunction and cognitive deficits during adulthoodExperimental Brain Research, 1992
- Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementiaJournal of Neuroscience Research, 1992
- Neurotransmitter enzyme abnormalities in senile dementiaJournal of the Neurological Sciences, 1977
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961